---
figid: PMC5486005__ijms-18-01182-g001
figlink: /pmc/articles/PMC5486005/figure/ijms-18-01182-f001/
number: Figure 1
caption: 'Key miRNAs in the resistance to BC treatment. Upregulation of four key miRNAs—miR-155,
  miR-222, miR-125b, and miR-21—is associated with the resistance to systemic therapy:
  Taxanes, Endocrine therapies, Targeted therapies, and Other agents. When dysregulated,
  these miRNAs disrupt genes or pathways (denoted by gray or yellow ovals, respectively)
  that lead to the molecular mechanisms associated with four of the hallmarks of cancer.
  Up-arrows denote up-regulated miRNA whereas T-Bar denote stop signaling pathway.'
pmcid: PMC5486005
papertitle: 'Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic
  Therapy: Future Clinical Implications.'
reftext: Alma D. Campos-Parra, et al. Int J Mol Sci. 2017 Jun;18(6):1182.
pmc_ranked_result_index: '5931'
pathway_score: 0.8635326
filename: ijms-18-01182-g001.jpg
figtitle: Key miRNAs in the resistance to BC treatment
year: '2017'
organisms: Homo sapiens
ndex: 5850e326-df13-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5486005__ijms-18-01182-g001.html
  '@type': Dataset
  description: 'Key miRNAs in the resistance to BC treatment. Upregulation of four
    key miRNAs—miR-155, miR-222, miR-125b, and miR-21—is associated with the resistance
    to systemic therapy: Taxanes, Endocrine therapies, Targeted therapies, and Other
    agents. When dysregulated, these miRNAs disrupt genes or pathways (denoted by
    gray or yellow ovals, respectively) that lead to the molecular mechanisms associated
    with four of the hallmarks of cancer. Up-arrows denote up-regulated miRNA whereas
    T-Bar denote stop signaling pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAPK14
  - MAPK13
  - AKT1
  - MAPK8
  - AKT3
  - MAPK12
  - MAPK10
  - MTOR
  - MAPK11
  - TGFB3
  - MAPK3
  - TGFB1
  - PTEN
  - AKT2
  - MAPK9
  - TGFB2
  - BAK1
  - STAT3
  - Gemcitabine
  - Taxanes
  - Cisplatin
  - Doxorubicin
  - Tamoxifen
  - Paclitaxel
  - Anthracyclines
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AKT/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: Bak
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
chemicals:
- word: Gemcitabine
  source: MESH
  identifier: C056507
- word: Taxanes
  source: MESH
  identifier: C080625
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Doxorubicin
  source: MESH
  identifier: D004317
- word: Tamoxifen
  source: MESH
  identifier: D013629
- word: Paclitaxel
  source: MESH
  identifier: D017239
- word: Anthracyclines
  source: MESH
  identifier: D018943
diseases: []
---
